Research ArticleSpecial Section on Transporters in Drug Disposition and Pharmacokinetic Prediction
Curcumin as an In Vivo Selective Intestinal Breast Cancer Resistance Protein Inhibitor in Cynomolgus Monkeys
Tsuyoshi Karibe, Tomoki Imaoka, Koji Abe and Osamu Ando
Drug Metabolism and Disposition May 2018, 46 (5) 667-679; DOI: https://doi.org/10.1124/dmd.117.078931
Tsuyoshi Karibe
Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan
Tomoki Imaoka
Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan
Koji Abe
Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan
Osamu Ando
Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleSpecial Section on Transporters in Drug Disposition and Pharmacokinetic Prediction
Features of Curcumin as an In Vivo Intestinal BCRP Inhibitor
Tsuyoshi Karibe, Tomoki Imaoka, Koji Abe and Osamu Ando
Drug Metabolism and Disposition May 1, 2018, 46 (5) 667-679; DOI: https://doi.org/10.1124/dmd.117.078931
Research ArticleSpecial Section on Transporters in Drug Disposition and Pharmacokinetic Prediction
Features of Curcumin as an In Vivo Intestinal BCRP Inhibitor
Tsuyoshi Karibe, Tomoki Imaoka, Koji Abe and Osamu Ando
Drug Metabolism and Disposition May 1, 2018, 46 (5) 667-679; DOI: https://doi.org/10.1124/dmd.117.078931
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement